Reuters logo
BRIEF-Biotest ‍sells US therapy business to Adma Biologics, Inc.​
June 7, 2017 / 7:06 AM / 6 months ago

BRIEF-Biotest ‍sells US therapy business to Adma Biologics, Inc.​

June 7 (Reuters) - BIOTEST AG:

* ‍SOLD US THERAPY BUSINESS TO ADMA BIOLOGICS, INC.​

* ‍RECEIVES 50% MINUS ONE SHARE OF ADMA​

* ‍RECEIVES ALSO DISTRIBUTION RIGHTS OF SPECIFIED CURRENT PRODUCT AND A RIGHT OF FIRST OFFER FOR DISTRIBUTION OF FUTURE PRODUCTS OF ADMA FOR EUROPE, NEAR AND MIDDLE EAST AND SELECTED ASIAN COUNTRIES​

* ‍AS PART OF TRANSACTION, BIOTEST HAS CONTRIBUTED EUR11.5 MILLION IN CASH AS WELL AS A EUR14 MILLION LOAN​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below